Dr. David Harrell
David Harrell, PhD, DABRM, FAARM, FRSPH
David Harrell, Owner of Harrell Bioscience Consulting, has two decades of experience in basic science research, translational research into clinical practice, strategic planning, innovation, technology development, and executive management. Dr. Harrell has ties in government, industry, and academia.
Dr. Harrell focuses his efforts on translational research and clinical development and application of basic science. In this focus area, he works with granting agencies, regulatory bodies (e.g., US Food and Drug Administration, European Medicines Agency), and government officials to bring technologies from the research bench to the clinic bedside.
Dr. Harrell is one of the founding members of the American Academy and Board of Regenerative Medicine (AABRM) and is the current the President of the AABRM; he is also the Editor-In-Chief of the Journal of the American Academy of Regenerative Medicine. Additionally, Dr. Harrell is Affiliated Research Scientist at BioScience Research Associates; formally the Center for Blood Research Laboratories which originated as CBR Biomedical Research Institute (now know as the Immune Disease Institute) and is affiliated academically with Harvard Medical School. Dr. Harrell also serves on the Multidisciplinary Neuroscience Alliance at the University of Central Florida College of Medicine.
Dr. Harrell is a Diplomat of the American Board of Regenerative Medicine and Fellow of the American Academy of Regenerative Medicine as well as Fellow of the Royal Society of Public Health. Dr. Harrell has served as the Chief Scientific Officer/Chief Scientist for NuroStar, Philips/Respironics, Harvest-Terumo, and RMTI; additionally he has been Adjunct Assistant Professor at MSNI and UCF College of Medicine. Dr. Harrell has received numerous national and international awards for his basic science and translational research and given over 50 Keynote Presentations with several of those being on topics never previously discussed.